4A’s Files Comments On Drug Pricing Transparency

Marketing & Communications

The 4A’s filed comments in December on proposed regulations by the Centers for Medicare & Medicaid (CMS) that would require all TV advertisements featuring prescription drugs and biological products to include the list price.